Genome-wide polygenic risk scores for hypertensive disease during pregnancy can also predict the risk for long-term

Seung Mi Lee1, Manu Shivakumar2, Brenda Xiao2

  • 1Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea; Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA; Department of Obstetrics and Gynecology, Seoul National University Hospital, Seoul, Korea.

Insights

Genetic predisposition for hypertensive disorders during pregnancy predicts long-term cardiovascular disease risk. High genetic risk is linked to increased atherosclerotic cardiovascular disease, including coronary artery disease and myocardial infarction.

Area of Science:

  • Cardiovascular epidemiology
  • Genetics of cardiovascular disease
  • Reproductive health

Background:

  • Hypertensive disorders during pregnancy (HDP) are linked to future cardiovascular disease (CVD).
  • The role of genetic predisposition for HDP in predicting long-term CVD risk remains unclear.

Purpose of the Study:

  • To assess the association between polygenic risk scores for HDP and long-term atherosclerotic cardiovascular disease (ASCVD) risk.
  • To determine if genetic risk for HDP can predict ASCVD development later in life.

Main Methods:

  • UK Biobank participants (n=164,575) of European descent with live births were analyzed.
  • Participants were stratified by polygenic risk scores for HDP into low, medium, and high-risk groups.
  • Incident ASCVD (coronary artery disease, myocardial infarction, ischemic stroke, peripheral artery disease) was evaluated.

Main Results:

  • Women with high genetic risk for HDP had higher baseline hypertension prevalence.
  • High genetic risk for HDP was associated with increased ASCVD risk, including coronary artery disease, myocardial infarction, and peripheral artery disease.
  • This association persisted even after adjusting for a history of HDP.

Conclusions:

  • High genetic risk for HDP is a significant predictor of future ASCVD.
  • Polygenic risk scores for HDP offer valuable insights into predicting long-term cardiovascular outcomes.
Abstract

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.7K
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
66.1K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
36
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
27
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
18